These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1134 related articles for article (PubMed ID: 34362430)

  • 21. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.
    Borkotoky S; Dey D; Hazarika Z
    Mol Biol Rep; 2023 Mar; 50(3):2713-2721. PubMed ID: 36562937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.
    Calcagnile M; Forgez P; Iannelli A; Bucci C; Alifano M; Alifano P
    Biochimie; 2021 Jan; 180():143-148. PubMed ID: 33181224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis.
    Kemenesi G; Tóth GE; Bajusz D; Keserű GM; Terhes G; Burián K; Zeghbib S; Somogyi BA; Jakab F
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
    Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
    Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor.
    Sinha S; Tam B; Wang SM
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants.
    Laffeber C; de Koning K; Kanaar R; Lebbink JHG
    J Mol Biol; 2021 Jul; 433(15):167058. PubMed ID: 34023401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2.
    Huang X; Zhang C; Pearce R; Omenn GS; Zhang Y
    J Proteome Res; 2020 Dec; 19(12):4844-4856. PubMed ID: 33175551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.
    da Costa CHS; de Freitas CAB; Alves CN; Lameira J
    Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.
    Xue X; Shi J; Xu H; Qin Y; Yang Z; Feng S; Liu D; Jian L; Hua L; Wang Y; Zhang Q; Huang X; Zhang X; Li X; Chen C; Guo J; Tang W; Liu J
    Sci Rep; 2021 Feb; 11(1):3187. PubMed ID: 33542420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection:
    AlGhamdi NA; Alsuwat HS; Borgio JF; AbdulAzeez S
    J Biomol Struct Dyn; 2022 Apr; 40(6):2635-2646. PubMed ID: 33138699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular basis for SARS-CoV-2 binding to dog ACE2.
    Zhang Z; Zhang Y; Liu K; Li Y; Lu Q; Wang Q; Zhang Y; Wang L; Liao H; Zheng A; Ma S; Fan Z; Li H; Huang W; Bi Y; Zhao X; Wang Q; Gao GF; Xiao H; Tong Z; Qi J; Sun Y
    Nat Commun; 2021 Jul; 12(1):4195. PubMed ID: 34234119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
    Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
    PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies.
    Samanta A; Alam SSM; Ali S; Hoque M
    Funct Integr Genomics; 2023 Jan; 23(1):36. PubMed ID: 36631570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species.
    Delgado Blanco J; Hernandez-Alias X; Cianferoni D; Serrano L
    PLoS Comput Biol; 2020 Dec; 16(12):e1008450. PubMed ID: 33284795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.
    Dash P; Turuk J; Behera SK; Palo SK; Raghav SK; Ghosh A; Sabat J; Rath S; Subhadra S; Rana K; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Dash S; Parida A; Pati S
    Int J Infect Dis; 2021 Mar; 104():491-500. PubMed ID: 33450373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding.
    Bate N; Savva CG; Moody PCE; Brown EA; Evans SE; Ball JK; Schwabe JWR; Sale JE; Brindle NPJ
    PLoS Pathog; 2022 Jul; 18(7):e1010733. PubMed ID: 35849637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2.
    Shu CJ; Huang X; Tang HH; Mo DD; Zhou JW; Deng C
    Zool Res; 2021 Mar; 42(2):170-181. PubMed ID: 33738989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.